| Joann Algorri, SLP | |
|
Calle Aquamarina 66 Villa Blanca, Caguas, PR 00725 | |
| (787) 743-1047 | |
| Not Available |
| Full Name | Joann Algorri |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Calle Aquamarina 66 Villa Blanca, Caguas, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811106297 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 626 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joann Algorri, SLP Hc-05 Box 55231, Caguas, PR 00725 Ph: (787) 413-0134 | Joann Algorri, SLP Calle Aquamarina 66 Villa Blanca, Caguas, PR 00725 Ph: (787) 743-1047 |
News Archive
Adding a thin coating of the biocompatible polymer poly(ethylene glycol) (PEG) to the surface of sulfur-modified, or thiolated, nanoparticles designed to fall apart inside tumors, prolongs the time that the resulting nanoparticles remain in tumors.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the United States Patent & Trademark Office has issued U.S. Patent No. 8,034,829 to Rexahn, entitled "5, 6, or 7-Substituted-3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof."
MDCT arthrography is better than MR arthrography for diagnosing glenoid rim osseous lesions, lesions that have been identified as potential causes of recurrence after shoulder surgery, according to a new study.
The Patient Advocate Foundation (PAF) a national non-profit resolving patient access to health care issues, medical financial limitations, insurance denials and multiple government program enrollments, including Medicaid and Social Security Disability Income announced today that it launched a new Colorectal Financial Aid Fund (FAF) beginning September 28, 2010.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
› Verified 2 days ago
Vivian M Ortega, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 66 Calle Aquamarina, Villa Blanca, Caguas, PR 00725 Phone: 787-743-1047 | |
Ana Gloria Davila Romney, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Santa Juana Ii, Calle 9 G8, Caguas, PR 00725 Phone: 787-955-1434 | |
Miss Jesselyn M Proenza, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Carretera 172, Urbanizacion Turabo Gardens, Caguas, PR 00726 Phone: 787-743-3038 | |
Lymari Segarra, M.S, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: J1 Calle Guyniabon, Parque Las Haciendas, Caguas, PR 00727 Phone: 787-691-3232 | |
Miss Jennifer Torres Rivera, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 47 Calle Turquesa, Villa Blanca, Caguas, PR 00725 Phone: 787-466-7817 | |
Mrs. Lourdes Santos Rolon I, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Hc 4 Box 46938, Caguas, PR 00727 Phone: 787-961-8484 | |
Jinnerva Miranda Polanco, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Bairoa Golden Gate Ii St G, Q-8, Caguas, PR 00727 Phone: 787-202-9850 |